NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO
On
Publishing of EU growth prospectus
The prospectus has been prepared in connection with the Rights Issue and has been approved by the
In addition to the Rights Issue, the board of directors of the Company may, based on the authorisation granted by the annual general meeting on
Registration forms for subscription of issued new shares without subscription rights can be obtained from Aktieinvest by telephone (+46 8 5065 1795) or via email (emittentservice@aktieinvest.se), from the first day of the subscription period (17 June 2021).
The prospectus has been prepared in accordance with Regulation (EU) 2017/1129 of the
Timetable for the Rights Issue
June 10, 2021 : Last day of trading in the share, including the right to receive subscription rights.June 11, 2021 : First day of trading in the share, excluding the right to receive subscription rights.June 14, 2021 : Record date for participation in the Rights Issue, i.e. holders of shares who are registered in the share register maintained byEuroclear Sweden AB on this date will receive subscription rights for participation in the Rights Issue with preferential right.June 17 –June 28, 2021 : Trading in subscription rights.June 17 –July 1, 2021 : Subscription period.July 7, 2021 : Expected day for publication of the outcome of the Rights Issue and the board of directors’ decision to resolve on the Over-allotment Issue.July 19, 2021 : Expected day for conversion of BTA (paid and subscribed for shares) to shares and admission of the newly issued shares to trading on Nasdaq First North Growth Market.
Advisors
Important information
The release, announcement or distribution of this press release may, in certain jurisdictions, be subject to restrictions. The recipients of this press release in jurisdictions where this press release has been published or distributed shall inform themselves of and follow such restrictions. The recipient of this press release is responsible for using this press release, and the information contained herein, in accordance with applicable rules in each jurisdiction. This press release does not constitute an offer, or a solicitation of any offer to sell or an offer to buy or subscribe for shares issued by the Company in any jurisdiction where such offer or invitation would be illegal. In a member state within the European Economic Area ("EEA"), securities referred to in the press release may only be offered in accordance with applicable exemptions under Regulation (EU) 2017/1129 of the
This press release is not an offer or invitation to acquire or subscribe for shares or other securities in
This release is not a prospectus in accordance to the definition in the Prospectus Regulation as has not been approved by any regulatory authority. In order for investors to fully understand the potential risks and benefits associated with a decision to participate in the Rights Issue, any investment decision should only be made based on the information in the prospectus. Thus, investors are encouraged to review the prospectus in its entirety. This press release constitutes an advertisement in accordance with article 2 k of the Prospectus Regulation.
To the extent this press release contains forward-looking statements, such statements does not constitute facts and are characterized by words such as “shall”, “expect”, “believe” “assess”, “intend”, “estimate” and similar expressions. Such statements reflect Nanexa’s intentions, views or present expectations or assumptions. Such forward-looking statements are based on Nanexa’s current plans, estimates and projections, which have been made to the best of Nanexa’s ability. However,
© Modular Finance, source